Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NMT1 | P30419 | 7/20 | 0.45 |
| ▸ | NMT2 | O60551 | 6/20 | 0.45 |
| ▸ | GSR | P00390 | 1/20 | 0.45 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.44 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.44 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.44 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.43 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.43 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.43 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.43 |
| ▸ | MMP2 | P08253 | 1/20 | 0.41 |
| ▸ | TERT | O14746 | 1/20 | 0.40 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.39 |
| ▸ | DPP4 | P27487 | 1/20 | 0.39 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.38 |
| ▸ | TLR2 | O60603 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29737833 | 0.95 | NMT1 (0.45) | NMT1NMT2GSRDPP8DPP9 | |
| SCHEMBL30123144 | 0.92 | NMT1 (0.46) | NMT1NMT2GSRDPP8DPP9 | |
| SCHEMBL18234163 | 0.92 | NMT1 (0.51) | NMT1NMT2PTGS1GSTK1MMP2 | |
| SCHEMBL30513899 | 0.92 | PTGS1 (0.52) | NMT1NMT2GSRDPP8DPP9 | |
| SCHEMBL31665964 | 0.91 | NMT1 (0.50) | NMT1NMT2PTGS1GSTK1MMP2 | |
| SCHEMBL18234267 | 0.91 | NMT1 (0.53) | NMT1NMT2PTGS1GSTK1TERT | |
| SCHEMBL29397470 | 0.91 | GSR (0.47) | NMT1NMT2GSRDPP8DPP9 | |
| SCHEMBL29569320 | 0.90 | GSR (0.46) | NMT1NMT2GSRDPP8DPP9 | |
| SCHEMBL29569055 | 0.90 | GSR (0.46) | NMT1NMT2GSRDPP8DPP9 | |
| SCHEMBL29569009 | 0.90 | GSR (0.46) | NMT1NMT2GSRDPP8DPP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12128110-B2 | Transglutaminase conjugation method and linker | PAUL SCHERRER INSTITUT (CH) | 2024-10-29 | — | — | US | claimed |
| US-20250161479-A1 | TRANSGLUTAMINASE CONJUGATION METHOD AND LINKER | PAUL SCHERRER INSTITUT (CH) | 2025-05-22 | — | — | US | disclosed |
| US-12128110-B2 | Transglutaminase conjugation method and linker | PAUL SCHERRER INSTITUT (CH) | 2024-10-29 | — | — | US | disclosed |
| US-20240350656-A1 | TRANSGLUTAMINASE CONJUGATION METHOD AND LINKER | PAUL SCHERRER INSTITUT (CH) | 2024-10-24 | — | — | US | disclosed |
| EP-4370150-A1 | OVERCOMING ANTIBODY-INTERFERENCE IN AVIANS | Intervet International B.V. (NL) | 2024-05-22 | — | — | EP | disclosed |
| WO-2023285489-A1 | OVERCOMING ANTIBODY-INTERFERENCE IN AVIANS | INTERVET INTERNATIONAL B.V. (NL) | 2023-01-19 | — | — | WO | disclosed |
| CN-114891759-A | Wx mutant protein based on gene editing technology and application of gene thereof in plant breeding | 江苏省农业科学院 | 2022-08-12 | — | — | CN | disclosed |
| CN-111197034-B | Wx mutant protein based on gene editing technology and application of gene thereof in plant breeding | 江苏省农业科学院 | 2022-07-29 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250161479-A1 | TRANSGLUTAMINASE CONJUGATION METHOD AND LINKER | TGM3, TGM2, TGM1 | NMT1 75/4885NMT2 76/4885GSR 781/4885 |
| US-12128110-B2 | Transglutaminase conjugation method and linker | TGM3, TGM2, TGM1 | NMT1 76/4885NMT2 80/4885GSR 716/4885 |
| US-20240350656-A1 | TRANSGLUTAMINASE CONJUGATION METHOD AND LINKER | TGM3, TGM2, TGM1 | NMT1 76/4885NMT2 79/4885GSR 710/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.